Form 8-K - Current report:
SEC Accession No. 0001641172-25-026390
Filing Date
2025-09-03
Accepted
2025-09-03 16:05:48
Documents
12
Period of Report
2025-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 55672
  Complete submission text file 0001641172-25-026390.txt   224747

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gnlx-20250827.xsd EX-101.SCH 3011
3 XBRL LABEL FILE gnlx-20250827_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE gnlx-20250827_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3816
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41599 | Film No.: 251289692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)